182 related articles for article (PubMed ID: 2573403)
1. Simultaneous measurement of endothelium-derived relaxing factor by bioassay and guanylate cyclase stimulation.
Kondo K; Mitchell JA; de Nucci G; Vane JR
Br J Pharmacol; 1989 Oct; 98(2):630-6. PubMed ID: 2573403
[TBL] [Abstract][Full Text] [Related]
2. Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells.
Martin W; White DG; Henderson AH
Br J Pharmacol; 1988 Jan; 93(1):229-39. PubMed ID: 2894877
[TBL] [Abstract][Full Text] [Related]
3. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
Ignarro LJ; Harbison RG; Wood KS; Kadowitz PJ
J Pharmacol Exp Ther; 1986 Jun; 237(3):893-900. PubMed ID: 2872327
[TBL] [Abstract][Full Text] [Related]
4. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
Mülsch A; Busse R; Bassenge E
Z Kardiol; 1989; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide.
Boulanger C; Schini VB; Moncada S; Vanhoutte PM
Br J Pharmacol; 1990 Sep; 101(1):152-6. PubMed ID: 2178013
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.
Ignarro LJ; Byrns RE; Buga GM; Wood KS
Circ Res; 1987 Dec; 61(6):866-79. PubMed ID: 2890446
[TBL] [Abstract][Full Text] [Related]
7. Differential control and calcium-dependence of production of endothelium-derived relaxing factor and prostacyclin by pig aortic endothelial cells.
White DG; Martin W
Br J Pharmacol; 1989 Jul; 97(3):683-90. PubMed ID: 2547481
[TBL] [Abstract][Full Text] [Related]
8. Different patterns of release of endothelium-derived relaxing factor and prostacyclin.
Mitchell JA; de Nucci G; Warner TD; Vane JR
Br J Pharmacol; 1992 Feb; 105(2):485-9. PubMed ID: 1373103
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of soluble guanylate cyclase by endothelium-derived relaxing factor from cultured endothelial cells.
Mülsch A; Böhme E; Busse R
Eur J Pharmacol; 1987 Mar; 135(2):247-50. PubMed ID: 2884122
[TBL] [Abstract][Full Text] [Related]
10. Formation of endothelium-derived relaxing factor in porcine kidney epithelial LLC-PK1 cells: an intra- and intercellular messenger for activation of soluble guanylate cyclase.
Ishii K; Chang B; Kerwin JF; Wagenaar FL; Huang ZJ; Murad F
J Pharmacol Exp Ther; 1991 Jan; 256(1):38-43. PubMed ID: 1671098
[TBL] [Abstract][Full Text] [Related]
11. Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses.
Mülsch A; Busse R; Bassenge E
Eur J Pharmacol; 1988 Dec; 158(3):191-8. PubMed ID: 2908105
[TBL] [Abstract][Full Text] [Related]
12. Does EDRF/NO regulate its own release by increasing endothelial cyclic GMP?
Kuhn M; Förstermann U
Basic Res Cardiol; 1991; 86 Suppl 2():27-35. PubMed ID: 1659373
[TBL] [Abstract][Full Text] [Related]
13. Activation of guanylate cyclase and inhibition of platelet aggregation by endothelium-derived relaxing factor released from cultured cells.
Hawkins DJ; Meyrick BO; Murray JJ
Biochim Biophys Acta; 1988 May; 969(3):289-96. PubMed ID: 2897209
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells.
Kuhn M; Otten A; Frölich JC; Förstermann U
J Pharmacol Exp Ther; 1991 Feb; 256(2):677-82. PubMed ID: 1847208
[TBL] [Abstract][Full Text] [Related]
15. Effect of calcium on endothelium-derived relaxing factor formation and cGMP levels in endothelial cells.
Schmidt K; Mayer B; Kukovetz WR
Eur J Pharmacol; 1989 Nov; 170(3):157-66. PubMed ID: 2559853
[TBL] [Abstract][Full Text] [Related]
16. Endothelium- and sydnonimine-induced responses of native and cultured aortic smooth muscle cells are not impaired by nitroglycerin tolerance.
Mülsch A; Busse R; Winter I; Bassenge E
Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):568-74. PubMed ID: 2570362
[TBL] [Abstract][Full Text] [Related]
17. Alkaline buffers release EDRF from bovine cultured aortic endothelial cells.
Mitchell JA; de Nucci G; Warner TD; Vane JR
Br J Pharmacol; 1991 Jun; 103(2):1295-302. PubMed ID: 1884092
[TBL] [Abstract][Full Text] [Related]
18. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
19. Effects of hypoxia and metabolic inhibitors on production of prostacyclin and endothelium-derived relaxing factor by pig aortic endothelial cells.
Richards JM; Gibson IF; Martin W
Br J Pharmacol; 1991 Jan; 102(1):203-9. PubMed ID: 1646057
[TBL] [Abstract][Full Text] [Related]
20. Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells.
Lückhoff A; Pohl U; Mülsch A; Busse R
Br J Pharmacol; 1988 Sep; 95(1):189-96. PubMed ID: 3064851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
